P-78 USE OF ARTERIAL CONDUITS IN LIVER TRANSPLANTATION: OUTCOMES IN A SINGLE CENTRE IN PERU

Abstract

Introduction: Being one of the South American countries with the cadaveric donor lowest rate, doesn't except us from having complex vascular inflow situation; Is in this context, the alternative of using arterial conduit to solve a poor arterial stream in recipients is always present. (ReTransplant, or risk factors of the Hepatic artery Thrombosis) Objective: Describe the outcome and the following of adult patient with arterial conduit in liver transplant at the Guillermo Almenara Irigoyen National Hospital 2000-2020. Results: We Retrospectively reviewed, From March 2000 to February 2020, 274 Adult cadaveric liver Transplants have been performed, from this cohort we show use of 33 aortohepatic arterial ducts (12%) and the primary etiology was: NASH 11 cases (33,3%), follow by AIH 06 cases(18,2%) and VHC, Cryptogenic, CBP each with 04 cases meaning 12.1% respectively. It had been used in primary transplants in 25 cases (75,8%) and in 7 retransplant (25,2%); In 01 case (3%) we used as an alternative for a second retransplant. The global survival for the first years was 75% and 3 years survival was 71%. We identify 03 cases of complication (9%), having 01 hepatic arterial thrombosis, 01 partial arterial conduit thrombosis and 01 psedoaneurism arterial conduit. Conclusion: Performing an arterial conduit must be one of the feasible alternatives in complex situation in any liver transplant group. It is a save technique with no negative impact on survival and it seems to be associate with other vascular complications.